Compare, Analyse ALEMBIC PHARMA with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC PHARMA   ACTAVIS
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
ACTAVIS
Dec-18
ALEMBIC PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs66414,220-   
Low Rs4129,539-   
Sales per share (Unadj.) Rs208.73,488.2-  
Earnings per share (Unadj.) Rs31.0-1,123.6-  
Cash flow per share (Unadj.) Rs37.1367.6-  
Dividends per share (Unadj.) Rs5.500-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs144.214,387.3-  
Shares outstanding (eoy) m188.52332.60-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.63.4 75.7%   
Avg P/E ratio x17.4-10.6 -164.2%  
P/CF ratio (eoy) x14.532.3 44.9%  
Price / Book Value ratio x3.70.8 452.0%  
Dividend payout %17.70-   
Avg Mkt Cap Rs m101,4613,951,174 2.6%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m7,4670-   
Avg. sales/employee Rs ThNM68,650.1-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-22,112.2-  
INCOME DATA
Net Sales Rs m39,3471,160,187 3.4%  
Other income Rs m9422,187 0.4%   
Total revenues Rs m39,4411,182,373 3.3%   
Gross profit Rs m8,73630,403 28.7%  
Depreciation Rs m1,152495,955 0.2%   
Interest Rs m18466,949 0.3%   
Profit before tax Rs m7,493-510,315 -1.5%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m0130,151 0.0%   
Tax Rs m1,568-6,467 -24.2%   
Profit after tax Rs m5,844-373,697 -1.6%  
Gross profit margin %22.22.6 847.2%  
Effective tax rate %20.91.3 1,650.7%   
Net profit margin %14.9-32.2 -46.1%  
BALANCE SHEET DATA
Current assets Rs m19,577475,848 4.1%   
Current liabilities Rs m14,896420,951 3.5%   
Net working cap to sales %11.94.7 251.4%  
Current ratio x1.31.1 116.3%  
Inventory Days Days9020 458.2%  
Debtors Days Days4566 68.4%  
Net fixed assets Rs m27,097131,327 20.6%   
Share capital Rs m3770-   
"Free" reserves Rs m26,8110-   
Net worth Rs m27,1884,785,228 0.6%   
Long term debt Rs m4,9931,685,052 0.3%   
Total assets Rs m47,7787,480,400 0.6%  
Interest coverage x41.7-6.6 -629.7%   
Debt to equity ratio x0.20.4 52.2%  
Sales to assets ratio x0.80.2 531.0%   
Return on assets %12.6-4.1 -307.7%  
Return on equity %21.5-7.8 -275.2%  
Return on capital %23.6-4.8 -487.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m13,3880-   
CASH FLOW
From Operations Rs m8,120414,491 2.0%  
From Investments Rs m-7,556227,709 -3.3%  
From Financial Activity Rs m590-711,391 -0.1%  
Net Cashflow Rs m1,153-68,845 -1.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 73.49 Rs / USD

Compare ALEMBIC PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ALEMBIC PHARMA With: AJANTA PHARMA  SUN PHARMA  NOVARTIS  UNICHEM LAB  BIOCON   



Today's Market

SGX Nifty Up 50 Points; Indicates Positive Opening for Indian Stock Markets(SGX Nifty)

The SGX Nifty opened on a positive note today. At 8:05 am, it was trading up by 50 points, or 0.3% higher at 14,760 levels.

Related Views On News

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

New Research: Our #1 Stock Pick Right Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ALEMBIC PHARMA SHARE PRICE


May 17, 2021 09:33 AM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS